The percentage of G-MDSC (CD11b+ CD33+ CD15+ CD14- HLA-DR- cells) was investigated in the PB of healthy donors (HD) and CML patients at diagnosis. This evidence concerns the gene CD14 and chronic myelogenous leukemia, BCR-ABL1 positive.